Anaphylm NDA Resubmission Hinges on Unverified Prodrug PK Equivalence, Not Just Delivery Innovation

Adrenaline auto-injector (AAI) underutilization and device limitations: Despite being the cornerstone of acute anaphylaxis management, AAIs are frequently not carried by patients and are often administered incorrectly — even by trained healthcare professionals and caregivers. Device-specific constraints include variable needle lengths that may be insufficient in obese patients or excessive in others, with injection depth and drug pharmacokinetics further confounded by BMI, soft tissue compression, and propulsion mechanics. Compounding this, there is a notable absence of validated assessment criteria and standardized regulatory requirements for next-generation devices.

Oral immunotherapy (OIT) tolerability and long-term sustainability concerns: OIT is associated with high rates of allergic adverse reactions during treatment and significant patient non-compliance, contributing to a substantial overall treatment burden. While earlier intervention may improve outcomes, it introduces its own set of clinical challenges. When omalizumab is used as an adjunct to OIT, the long-term durability of tolerance following omalizumab discontinuation remains uncertain.

Allergen immunotherapy (AIT) — efficacy, safety, and adherence deficits: Subcutaneous immunotherapy (SCIT) is limited by well-documented disadvantages spanning efficiency, safety profile, treatment duration, and patient compliance. Local and systemic allergic reactions occur commonly, and although anaphylaxis is reported rarely, it remains a clinically significant risk.

Sublingual immunotherapy (SLIT) — local and systemic adverse event burden: SLIT is associated with a high incidence of local side effects, affecting approximately 40.83% of patients. While systemic adverse events are less frequent — occurring in approximately 1.09% of patients — anaphylaxis has been reported in 0.13% of the SLIT population, representing a non-negligible safety consideration even with this less invasive route of administration.